Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real‐world data study

Santos‐García, Diego; López Manzanares, Lydia; Muro, Inés; Lorenzo‐Barreto, Pablo; Casas Peña, Elena; García-Ramos, R.; Fernández Valle, Tamara; Morata‐Martínez, Carlos; Baviera‐Muñoz, Raquel; Martínez‐Torres, Irene; Álvarez‐Sauco, María; Alonso-Modino, D.; Legarda, Inés; Fuensanta Valero‐García, María; Andrés Suárez‐Muñoz, José; Carlos Martínez‐Castrillo, Juan; Belén Perona Moratalla, Ana; María Salom, José; Cubo, Esther; Valero‐Merino, Caridad; López Ariztegui, Núria; Sánchez Alonso, Pilar; Novo Ponte, S.; Gamo González, Elisa; Martín García, Raquel; Espinosa, Raúl; Carmona‐Abellán, Mar; Feliz, Cici; Ruiz, Pedro; Muñoz Ruíz, Teresa; Fernández Rodríguez, Beatriz; Mata, Marina

doi:10.1111/ene.16535

Public

Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real‐world data study

Published in European Journal of Neurology • Oct 28, 2024

Authors:

Diego Santos‐García

Lydia López Manzanares

Inés Muro

Abstract

BACKGROUND AND PURPOSE: Levodopa-entacapone-carbidopa intestinal gel (LECIG) infusion is a recently developed device-aided therapy for advanced Parkinson disease (PD) patients. The aim of this study was to report real-world evidence about the effectiveness, tolerability, and safety of LECIG in PD pa...

Subject

Entacapone

Medicine

Tolerability

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!